Star Combo Pharma Ltd. Financial Overview
Star Combo Pharma Ltd.'s market cap is currently AU$29.70M. The company's EPS TTM is AU$0.037; its P/E ratio is 5.66; and it has a dividend yield of 1.72%. Star Combo Pharma Ltd. is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
